JAZZ vs NWE · P/E 1988, rev $2.28B vs P/E 25, rev $1.61B
Jazz Pharmaceuticals PLC (JAZZ) versus NorthWestern Corporation (NWE) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
NorthWestern Corporation (NWE) is a utilities - regulated electric company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported NWE revenue for 2025-12-31 was $1.61B. Net income was $181.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. NWE currently screens at market cap $4.26B and trailing P/E 25.5.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. NWE currently screens at market cap $4.26B and trailing P/E 25.5.
Not investment advice. Open the JAZZ and NWE stock pages for the full models.
Not investment advice.